| Molecule | Cat. No. | Product Name | Espèce | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| MIF | Avitag MIF-H82E7 | Biotinylated Human MIF Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| IPG-1094 | IPG-1094; IPG-001 | Phase 2 Clinical | Nanjing Immunophage Biotech Co Ltd | Brain metastases; Brain Neoplasms; Hematologic Neoplasms; Lupus Nephritis; Multiple Myeloma; Multiple Sclerosis; Psoriasis; Solid tumours | Details |
| TRP2-electroporated autologous dendritic cell therapy (Memorial Sloan-Kettering) | Phase 1 Clinical | Memorial Sloan Kettering Cancer Center | Melanoma | Details | |
| STP-1 | STP-1; STP1 | Phase 1 Clinical | Stalicla Sa | Autism Spectrum Disorder | Details |
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Plus ancien nom de marque | Pays d'approbation le plus ancien | Indication la plus ancienne | Société d'approbation la plus ancienne | Date d'approbation la plus ancienne | Indication | Essai clinique |
|---|---|---|---|---|---|---|---|---|---|---|
| Ibudilast | KC-404; AV-411; MN-166 | Approved | Kyorin Pharmaceutical Co Ltd | Ketas, Pinatos, Eyevinal | Japan | Asthma; Multiple Sclerosis; Neuralgia | Kyorin Pharmaceutical Co Ltd | Alcoholism; Amyotrophic Lateral Sclerosis; Asthma; Diabetic Neuropathies; Headache Disorders, Secondary; HIV Infections; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuralgia; Opioid-Related Disorders; Pneumonia, Viral; Substance-Related Disorders | Details |
